HomeNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
Nakaraang pagsara
$1.48
Sakop ng araw
$1.42 - $1.60
Sakop ng taon
$1.29 - $99.75
Market cap
38.40M USD
Average na Volume
447.80K
P/E ratio
0.55
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 521.00K | -78.66% |
Gastos sa pagpapatakbo | 1.21M | -28.89% |
Net na kita | -1.29M | -6.68% |
Net profit margin | -248.18 | — |
Kita sa bawat share | — | — |
EBITDA | -1.17M | 31.23% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.31M | 197.55% |
Kabuuang asset | 3.49M | -10.06% |
Kabuuang sagutin | 1.85M | -33.94% |
Kabuuang equity | 1.63M | — |
Natitirang share | 25.20M | — |
Presyo para makapag-book | -0.66 | — |
Return on assets | -56.21% | — |
Return on capital | -74.07% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.29M | -6.68% |
Cash mula sa mga operasyon | -1.80M | 12.71% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | -1.32M | -163.17% |
Net change in cash | -3.12M | -12,096.15% |
Malayang cash flow | -1.22M | 35.34% |
Tungkol
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Itinatag
2000
Headquarters
Website
Mga Empleyado
14
